Back close

Design, synthesis, molecular modeling of heterodimer and inhibitors of α-amylase as hypoglycemic agents

Publication Type : Journal Article

Publisher : Molecular Diversity, Springer science

Url : https://doi.org/10.1007/s11030-022-10414-8

Keywords : Antioxidant activity; Heterodimer; Molecular modeling; PPARγ; α-amylase.

Campus : Kochi

School : School of Pharmacy

Year : 2022

Abstract : A series of rosiglitazone-based heterodimers were designed and synthesized, and their α-amylase and antioxidant activity was evaluated. The binding mode of the compounds at the active site of PPARγ and α-amylase enzyme was explored using MolDock docking method. In molecular docking studies against crystal structure of PPARγ (PDB code: 1FM6), compounds 10 and 13 showed interaction with amino acids Arg379, Asp379, Asn385, Ala387, Glu388, Val389, Glu390, and Lys438. Docking results of α-amylase enzyme (PDB code: 5EOF) with compounds 10 and 13 showed excellent interaction with amino acids Ala169, Lys172, Asp173, Tyr174, Val175, Arg176, and Lys178. Depending on the docking score, the designed compounds were selectively prioritized for synthesis. All synthesized compounds were subjected to in vitro α-amylase activity and antioxidant activity. Compounds 10 and 13 were to possess higher potency than acarbose, and most of the compounds showed antioxidant activity. Additionally, the most active compound 10 was evaluated for in vivo anti-diabetic activity.

Cite this Research Publication : Manisha Nidhar, Ved Prakash Singh, Pratima Yadav, Ranjeet Kumar, Priyanka Sonker, and Ashish Kumar Tewari, Design, synthesis, molecular modeling of heterodimer and inhibitors of α-amylase as hypoglycemic agents, Molecular Diversity, 2022, 10.1007/s11030-022-10414-8.

Admissions Apply Now